The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of hypersensitivity is listed in the xience sierra everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling, the additional xience pros device referenced in b5 is filed under a separate medwatch report numbers.
|
It was reported that the on september 12, 2022, a 3.5x18mm xience pros stent and a 3.5x28mm xience pros stent were implanted; however, a week later the patient began to experiencing an allergic reaction near back / buttocks.It is unknown if any treatment has been provided.There was no clinically significant delay in the procedure and no adverse patient effects during the procedure.No additional information was provided.
|